Correction to: High rates of Cefiderocol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patients.
作者信息
Naumann Hans Theodor, Höhl Rainer, Kinzig Martina, Salat Sophie, Bartsch Vanessa, Sörgel Fritz, Bertram Ralph, Steinmann Joerg
机构信息
Institute of Clinical Microbiology, Infectious Diseases and Infection Control, Nuremberg General Hospital, Paracelsus Medical University, Nuremberg, Germany.
Intensive Care Unit, Department of Medicine 1, University Hospital Carl Gustav Carus, TU, Dresden, Dresden, Germany.
出版信息
Crit Care. 2025 Aug 22;29(1):380. doi: 10.1186/s13054-025-05583-5.
Abstract
摘要
相似文献
1
Correction to: High rates of Cefiderocol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patients.对《头孢地尔血浆靶标达标率高：31例重症监护病房危重患者的回顾性队列研究结果》的更正
Crit Care. 2025 Aug 22;29(1):380. doi: 10.1186/s13054-025-05583-5.
2
High rates of cefiderocol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patients.头孢地尔血浆靶标达成率高：一项针对31例重症监护病房危重症患者的回顾性队列研究结果
Crit Care. 2024 Dec 30;28(1):438. doi: 10.1186/s13054-024-05214-5.
3
Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.肾功能在标准剂量美罗培南治疗危重症患者后目标未达标风险评估中的作用：一项前瞻性观察研究。
Crit Care. 2017 Oct 21;21(1):263. doi: 10.1186/s13054-017-1829-4.
4
Real-world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram-negative infections: Results from a retrospective study.头孢地尔在多重耐药革兰阴性菌感染重症患者中的真实世界有效性和安全性：一项回顾性研究的结果
Biomed Rep. 2025 Jul 22;23(4):156. doi: 10.3892/br.2025.2034. eCollection 2025 Oct.
5
Target-site cefiderocol pharmacokinetics in soft tissues of healthy volunteers.健康志愿者软组织中头孢地尔的靶点部位药代动力学。
J Antimicrob Chemother. 2024 Dec 2;79(12):3281-3288. doi: 10.1093/jac/dkae359.
6
Comparative analysis of outcomes between anemic and non-anemic critically ill elderly patients in a geriatric ICU in Egypt: A focused study.埃及一家老年重症监护病房中贫血与非贫血老年重症患者结局的比较分析：一项重点研究。
J Crit Care Med (Targu Mures). 2025 Jul 31;11(3):290-300. doi: 10.2478/jccm-2025-0028. eCollection 2025 Jul.
7
Prognostic value of the lactate-to-albumin ratio in critically ill chronic heart failure patients with sepsis: insights from a retrospective cohort study.乳酸与白蛋白比值在合并脓毒症的重症慢性心力衰竭患者中的预后价值：一项回顾性队列研究的见解
Front Med (Lausanne). 2025 Jul 15;12:1593524. doi: 10.3389/fmed.2025.1593524. eCollection 2025.
8
Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with OXA-48 or infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design.头孢他啶/阿维巴坦持续输注与间歇给药治疗产OXA-48或[此处原文缺失相关信息]感染的重症患者：一项单中心随机开放标签试验（ZAVICONT）。原理与设计。
Front Pharmacol. 2025 Aug 7;16:1618987. doi: 10.3389/fphar.2025.1618987. eCollection 2025.
9
Susceptibility toward cefiderocol and sulbactam-durlobactam in extensively drug-resistant detected from ICU admission screening in Hanoi, Vietnam, 2023.2023年在越南河内的重症监护病房入院筛查中检测到的广泛耐药菌对头孢地尔和舒巴坦-杜洛巴坦的敏感性。
Microbiol Spectr. 2025 Jul;13(7):e0083225. doi: 10.1128/spectrum.00832-25. Epub 2025 Jun 9.
10
Early versus late tracheostomy in critically ill COVID-19 patients.危重症 COVID-19 患者的早期与晚期气管切开术。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD015532. doi: 10.1002/14651858.CD015532.
本文引用的文献
1
High rates of cefiderocol plasma target attainment: results of a retrospective cohort study in 31 critically ill ICU patients.头孢地尔血浆靶标达成率高：一项针对31例重症监护病房危重症患者的回顾性队列研究结果
Crit Care. 2024 Dec 30;28(1):438. doi: 10.1186/s13054-024-05214-5.
Zotero 插件